Faleck Herbert J 4
4 · Edge Therapeutics, Inc. · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Faleck Herbert J
Chief Medical Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-01-02+50,000→ 50,000 totalExercise: $10.10From: 2019-01-02Exp: 2028-01-02→ Common Stock (50,000 underlying)